Saltar al contenido
Merck

Increased expression of fibroblast growth factor 23 is the signature of a deteriorated Ca/P balance in ageing laying hens.

Scientific reports (2020-12-05)
A Gloux, N Le Roy, N Même, M L Piketty, D Prié, G Benzoni, J Gautron, Y Nys, A Narcy, M J Duclos
RESUMEN

The present study concerned the effect of ageing in laying hens, from 23 to 90 weeks of age, on the regulation of Ca metabolism related to the requirement for eggshell mineralization. Samples were collected from parathyroid gland (PG), liver, jejunum, medullary bone (MB) and kidney for a quantitative study of candidate gene expression. Although parathyroid hormone (PTH) gene expression in the PG did not vary with age, a stronger challenge to Ca homeostasis was suggested in aged hens. Indeed gene expression of Ca transporters , Vitamin D Receptor (VDR) in the jejunum, and that of transient receptor potential channel subfamily V member 5 (TRPV5) in the kidney decreased. This could exacerbate bone resorption and impair bone accretion, as attested by a higher expression of the Carbonic Anhydrase 2 (CA2) gene and a lower expression of collagen type I alpha 1 chain (COL1A1) in the MB. The increased expression of Fibroblast Growth Factor 23 (FGF23) in the MB likely contributed to the decreased plasma levels of 1.25(OH)2D3 and the altered expression of target genes under its regulation. Our data highlights the molecular mechanisms underlying the osteoporotic syndrome previously documented in aged laying hens, thus providing new perspectives for future interventions.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Reactivo TRI®, For processing tissues, cells cultured in monolayer or cell pellets
Sigma-Aldrich
Reactivo TRI®, LS, For processing fluid samples such as cell suspensions, CSF, and amniotic fluid.